Han Zhang

TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild-type ALK and ALK-resistant Mutations

Brion W. Murray, Dayong Zhai, Wei Deng et al. · Molecular Cancer Therapeutics · 2021 · 84 citations · Full text

<i>CMTR1-ALK</i>: an <i>ALK</i> fusion in a patient with no response to ALK inhibitor crizotinib

Xue Du, Yun Shao, Hongjun Gao et al. · Cancer Biology & Therapy · 2018 · 31 citations · Full text

Design, Synthesis, and Biological Evaluation of Pyridineamide Derivatives Containing a 1,2,3-Triazole Fragment as Type II c-Met Inhibitors

Hehua Xiong, Jianxin Cheng, Jianqing Zhang et al. · Molecules · 2019 · 22 citations · Full text

Abstract 5226: TPX-0131: A next generation macrocyclic ALK inhibitor that overcomes ALK resistant mutations refractory to current approved ALK inhibitors

J. Jean Cui, Evan Rogers, Dayong Zhai et al. · Cancer Research · 2020 · 20 citations

Alk Resistant Mutations, Pharmacotherapy, Cancer Biology +23

The most bioactive fraction of stir-fried Radix Paeoniae Alba regulating IL-6/STAT3 signaling pathway in allergic asthma mouse

Xianan Sang, Xuedong Wan, Han Zhang et al. · Journal of Ethnopharmacology · 2022 · 16 citations

Inflammation, Asthma, Cytokine +9